WCMNX
Price
$13.81
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
WRGCX
Price
$7.47
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

WCMNX vs WRGCX

Header iconWCMNX vs WRGCX Comparison
Open Charts WCMNX vs WRGCXBanner chart's image
WCM Small Cap Growth Investor
Price$13.81
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Delaware Ivy Small Cap Growth C
Price$7.47
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
WCMNX vs WRGCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
WCMNX vs. WRGCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WCMNX is a StrongBuy and WRGCX is a Buy.

FUNDAMENTALS
Fundamentals
WRGCX has more cash in the bank: 1.35B vs. WCMNX (43.4M). WCMNX (0.00) and WRGCX (0.00) have matching dividends . WCMNX was incepted earlier than WRGCX: WCMNX (5 years) vs WRGCX (32 years). WRGCX is a more actively managed with annual turnover of: 51.00 vs. WCMNX (48.00). WCMNX (1000) and WRGCX (1000) have matching initial minimum investment requirements. WCMNX annual gain was more profitable for investors over the last year : 25.66 vs. WRGCX (17.27). WCMNX return over 5 years is better than : 35.00 vs. WRGCX (-43.66).
WCMNXWRGCXWCMNX / WRGCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years32 years-
Gain YTD13.19718.19673%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets43.4M1.35B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year25.6617.27149%
Returns for 3 years-13.85-55.3325%
Returns for 5 years35.00-43.66-80%
Returns for 10 yearsN/A-53.51-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLRC15.980.01
+0.06%
SLR Investment Corp
VTR64.45-0.03
-0.05%
Ventas
HAYW15.78-0.12
-0.75%
Hayward Holdings
REKR1.14-0.01
-1.29%
Rekor Systems
SNSE0.53-0.01
-2.66%
Sensei Biotherapeutics